PMID: 10812957May 17, 2000Paper

Selection, design and evaluation of new radioligands for PET studies of cardiac adrenoceptors

Pharmaceutica acta Helvetiae
V W PikePaolo G Camici

Abstract

Changes in the numbers of human cardiac adrenoceptors (ARs) are associated with various diseases, such as myocardial ischemia, congestive heart failure, cardiomyopathy and hypertension. There is a clear need for capability to assess human cardiac ARs directly in vivo. Positron emission tomography (PET) is an imaging technique that provides this possibility, if effective radioligands can be developed for the targeted ARs. Here, the status of myocardial AR radioligand development for PET is described. Currently, there exist effective radioligands for imaging beta-ARs in human myocardium. One of these, [11C](S)-CGP 12177, is applied extensively to clinical research with PET, sometimes with other tracers of other aspects of the noradrenalin system. Alternative radioligands are in development for beta-ARs, including beta 1-selective radioligands. A promising radioligand for imaging myocardial alpha 1-ARs, [11C]GB67, is now being evaluated in human PET experiments.

References

Jan 1, 1991·Circulation·H E Morgan, K M Baker
Mar 1, 1990·Journal of Medicinal Chemistry·D M WielandP S Sherman
Nov 1, 1983·The International Journal of Applied Radiation and Isotopes·G BergerD Comar
Jan 1, 1980·The Journal of Clinical Investigation·D J SheridanP B Corr
Jul 22, 1982·The New England Journal of Medicine·M R BristowE B Stinson
Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Nov 1, 1983·Journal of the American College of Cardiology·C KawaiA Matsumori
Jan 20, 1995·Journal of Chromatography. B, Biomedical Applications·A van WaardeW Vaalburg
Nov 15, 1993·Journal of the American College of Cardiology·D C LefroyP Nihoyannopoulos
Jul 1, 1996·European Journal of Nuclear Medicine·T Jones
Apr 12, 1996·Journal of Chromatography. B, Biomedical Applications·A van WaardeW Vaalburg
Nov 1, 1996·European Heart Journal·L ChoudhuryPaolo G Camici
Jul 21, 1998·Journal of the American College of Cardiology·M SchäfersPaolo G Camici
Sep 29, 2000·Physics in Medicine and Biology·T J SpinksR Nutt

Citations

Sep 15, 2004·European Journal of Pharmacology·P H ElsingaWillem Vaalburg
Mar 31, 2006·Public Health Nutrition·Susan Quine, Stephen Morrell
Nov 3, 2004·CNS Spectrums·J McConathyM M Goodman
Sep 10, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Santosh Reddy AlluriKun-Eek Kil

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.